Emergent BioSolutions to Release First Quarter 2017 Financial Results and Conduct a Conference Call on May 4, 2017
April 20 2017 - 7:00AM
Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call
on Thursday, May 4, 2017 at 5:00 pm (Eastern Time) to discuss the
financial results for the first quarter of 2017, recent business
developments, revenue guidance for the second quarter of 2017, and
revenue and net income guidance for full year 2017.
This conference call can be accessed live by telephone or via
webcast:
Live
Teleconference Information:Dial in
number: (855) 766-6521International dial in: (262)
912-6157Conference ID: 29691796 |
|
Live Webcast
Information: |
Visit
http://edge.media-server.com/m/p/523ryq7t for the live webcast
feed. |
A replay of the call can be accessed on Emergent’s website
emergentbiosolutions.com under “Investors.”
About Emergent BioSolutionsEmergent
BioSolutions Inc. is a global life sciences company seeking to
protect and enhance life by focusing on providing specialty
products for civilian and military populations that address
accidental, intentional, and naturally emerging public health
threats. Through our work, we envision protecting and enhancing 50
million lives with our products by 2025. Additional information
about the company may be found at emergentbiosolutions.com. Follow
us @emergentbiosolu.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com
Media Contact:
Tracey Schmitt Lintott
Senior Vice President, Global Public Affairs
240-631-3281
SchmittT@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024